BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37292750)

  • 1. Structural principles of peptide-centric Chimeric Antigen Receptor recognition guide therapeutic expansion.
    Sun Y; Florio TJ; Gupta S; Young MC; Marshall QF; Garfinkle SE; Papadaki GF; Truong HV; Mycek E; Li P; Farrel A; Church NL; Jabar S; Beasley MD; Kiefel BR; Yarmarkovich M; Mallik L; Maris JM; Sgourakis NG
    bioRxiv; 2023 May; ():. PubMed ID: 37292750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion.
    Sun Y; Florio TJ; Gupta S; Young MC; Marshall QF; Garfinkle SE; Papadaki GF; Truong HV; Mycek E; Li P; Farrel A; Church NL; Jabar S; Beasley MD; Kiefel BR; Yarmarkovich M; Mallik L; Maris JM; Sgourakis NG
    Sci Immunol; 2023 Dec; 8(90):eadj5792. PubMed ID: 38039376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules.
    Papadaki GF; Ani O; Florio TJ; Young MC; Danon JN; Sun Y; Dersh D; Sgourakis NG
    Front Immunol; 2023; 14():1116906. PubMed ID: 36761745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of intracellular oncoproteins with peptide-centric CARs.
    Yarmarkovich M; Marshall QF; Warrington JM; Premaratne R; Farrel A; Groff D; Li W; di Marco M; Runbeck E; Truong H; Toor JS; Tripathi S; Nguyen S; Shen H; Noel T; Church NL; Weiner A; Kendsersky N; Martinez D; Weisberg R; Christie M; Eisenlohr L; Bosse KR; Dimitrov DS; Stevanovic S; Sgourakis NG; Kiefel BR; Maris JM
    Nature; 2023 Nov; 623(7988):820-827. PubMed ID: 37938771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
    Yarmarkovich M; Marshall QF; Warrington JM; Premaratne R; Farrel A; Groff D; Li W; di Marco M; Runbeck E; Truong H; Toor JS; Tripathi S; Nguyen S; Shen H; Noel T; Church NL; Weiner A; Kendsersky N; Martinez D; Weisberg R; Christie M; Eisenlohr L; Bosse KR; Dimitrov DS; Stevanovic S; Sgourakis NG; Kiefel BR; Maris JM
    Nature; 2021 Nov; 599(7885):477-484. PubMed ID: 34732890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity.
    Maus MV; Plotkin J; Jakka G; Stewart-Jones G; Rivière I; Merghoub T; Wolchok J; Renner C; Sadelain M
    Mol Ther Oncolytics; 2016; 3():1-9. PubMed ID: 29675462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties.
    Fujiwara K; Masutani M; Tachibana M; Okada N
    Biochem Biophys Res Commun; 2020 Jun; 527(2):350-357. PubMed ID: 32216966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.
    Hwang MS; Miller MS; Thirawatananond P; Douglass J; Wright KM; Hsiue EH; Mog BJ; Aytenfisu TY; Murphy MB; Aitana Azurmendi P; Skora AD; Pearlman AH; Paul S; DiNapoli SR; Konig MF; Bettegowda C; Pardoll DM; Papadopoulos N; Kinzler KW; Vogelstein B; Zhou S; Gabelli SB
    Nat Commun; 2021 Sep; 12(1):5271. PubMed ID: 34489470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobody-based CAR T cells targeting intracellular tumor antigens.
    Li H; Zhong D; Luo H; Shi W; Xie S; Qiang H; Zhu L; Gao L; Liu J; Sun S; Ding Z; Yang X; Lu X
    Biomed Pharmacother; 2022 Dec; 156():113919. PubMed ID: 36411612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Structural Principles of PC-CARs Can Expand Therapeutic Application.
    Cancer Discov; 2023 Dec; ():OF1. PubMed ID: 38099696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma.
    Zhang C; Wang L; Zhang Q; Shen J; Huang X; Wang M; Huang Y; Chen J; Xu Y; Zhao W; Qi Y; Li Y; Ou Y; Yang Z; Qian C
    Front Immunol; 2023; 14():1182409. PubMed ID: 37304295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
    Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
    J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.
    Sun Y; Young MC; Woodward CH; Danon JN; Truong HV; Gupta S; Winters TJ; Font-Burgada J; Burslem GM; Sgourakis NG
    Proc Natl Acad Sci U S A; 2023 Jun; 120(25):e2304055120. PubMed ID: 37310998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
    Tian M; Cheuk AT; Wei JS; Abdelmaksoud A; Chou HC; Milewski D; Kelly MC; Song YK; Dower CM; Li N; Qin H; Kim YY; Wu JT; Wen X; Benzaoui M; Masih KE; Wu X; Zhang Z; Badr S; Taylor N; Croix BS; Ho M; Khan J
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35852863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.
    Han C; Sim SJ; Kim SH; Singh R; Hwang S; Kim YI; Park SH; Kim KH; Lee DG; Oh HS; Lee S; Kim YH; Choi BK; Kwon BS
    Nat Commun; 2018 Feb; 9(1):468. PubMed ID: 29391449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse.
    Wang SS; Luong K; Gracey FM; Jabar S; McColl B; Cross RS; Jenkins MR
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944696
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.